• UCB Receives Positive EU Recommendation for First-Ever Thymidine Kinase 2 Deficiency Treatment BRUSSELS, Belgium – Global biopharmaceutical company UCB announced on January…
• Lonza Reports 21.7% Sales Growth for 2025, Boosts Dividend and Issues Strong 2026 Outlook BASEL, Switzerland – Lonza Group reported on January…
• Austrian Post Group Sells Majority Stake in Pharmaceutical Wholesaler AEP to The Platform Group VIENNA, Austria – The Austrian Post Group announced…
• Diasorin Signs Exclusive U.S. Distribution Deal with Fisher Scientific for in-house testing platform SALUGGIA, Italy – Diasorin announced on January 26, 2026,…
• AstraZeneca to Delist from Nasdaq, Complete Direct Listing on NYSE CAMBRIDGE, UK – AstraZeneca announced on Tuesday it will voluntarily delist its…
• UPDATE: Hikma Pharmaceuticals Launches Denosumab Biosimilars Enoby™ and Xtrenbo™ in US Market LONDON, United Kingdom – Hikma Pharmaceuticals PLC announced on January…
• SAP and Fresenius Announce Strategic Partnership to Advance AI in Healthcare BAD HOMBURG, Germany – Fresenius and SAP announced on January 19…
• Novartis to Build Fourth US Radioligand Therapy Plant in Florida BASEL, Switzerland – Novartis announced on January 9 its plans to construct…